542
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1α through the NF90/NF45 complex

, , , , &
Pages 1034-1047 | Received 15 Sep 2021, Accepted 24 Jan 2022, Published online: 21 Feb 2022

References

  • Groza M, Zimta AA, Irimie A, et al. Recent advancements in the study of breast cancer exosomes as mediators of intratumoral communication. J Cell Physiol. 2020;235(2):691–705.
  • Guan XF, Liu Z, and Zhao Z, et al. Emerging roles of low-density lipoprotein in the development and treatment of breast cancer. Lipids Health Dis. 2019;18(1) ;137-+.
  • Yin L, Duan -J-J, and Bian X-W, et al. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22(1):61-+.
  • Dass SA, Tan KL, and Selva Rajan R, et al. Triple negative breast cancer: a review of present and future diagnostic modalities. Medicina-Lithuania. 2021;57(1):62-+.
  • Qavi Q, Alkistawi F, and Kumar S, et al. Male triple-negative breast cancer. Cureus. 2021;13(4):e14542.
  • Qiu J, Xue X, Hu C, et al. Comparison of clinicopathological features and prognosis in triple-negative and non-triple negative breast cancer. J Cancer. 2016;7(2):167–173.
  • Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist. 2004;9:10–17.
  • Reiterer M, Colaco R, and Emrouznejad P, et al. Acute and chronic hypoxia differentially predispose lungs for metastases. Sci Rep. 2019;9(1): 10246-+.
  • Hajizadeh F, Okoye I, and Esmaily M, et al. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sci. 2019; 237;116952-+.
  • de Heer Ec, Jalving M, Harris AL, et al. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Investig. 2020;130(10):5074–5087.
  • Lin A, Li C, Xing Z, et al. The LINK-A lncRNA activates normoxic HIF1 alpha signalling in triple-negative breast cancer. Nat Cell Biol. 2016;18(2):213-+.
  • Chen X, Iliopoulos D, Zhang Q, et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1 alpha pathway. Nature. 2014;508(7494):103-+.
  • Tosatto A, Sommaggio R, Kummerow C, et al. The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1. EMBO Mol Med. 2016;8(5):569–585.
  • Chen Y, Zhang B, Bao L, et al. ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. J Clin Investig. 2018;128(5):1937–1955.
  • Xiang L, Gilkes DM, Chaturvedi P, et al. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer. J Mol Med Jmm. 2014;92(2):151–164.
  • Ye G, Guo L, Xing Y, et al. Identification of prognostic biomarkers of prostate cancer with long non-coding RNA-mediated competitive endogenous RNA network. Exp Ther Med. 2019;17(4):3035–3040.
  • He M, Lin Y, Xu Y. Identification of prognostic biomarkers in colorectal cancer using a long non-coding RNA-mediated competitive endogenous RNA network. Oncol Lett. 2019;17(3):2687–2694.
  • Song C, Sun P, He Q, et al. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/beta-catenin signaling. Eur Rev Med Pharmacol Sci. 2019;23(10):4234–4242.
  • Tian Y, Yu M, Sun L, et al. Long non-coding RNA00887 reduces the invasion and metastasis of non-small cell lung cancer by causing the degradation of miRNAs. Oncol Rep. 2019;42(3):1173–1182.
  • Xing Z, Zhang Z, Gao Y, et al. The lncRNA LINC01194/miR-486-5p axis facilitates malignancy in non-small cell lung cancer via regulating CDK4. Onco Targets Ther. 2020;13:151–163.
  • Zhang D, Zhang H, Wang X, et al. LINC01518 knockdown inhibits tumorigenicity by suppression of PIK3CA/Akt pathway in oesophageal squamous cell carcinoma. Artif Cells Nanomed Biotechnol. 2019;47(1):4284–4292.
  • Mao C, Wang X, Liu Y, et al. A G3BP1-Interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53. Cancer Res. 2018;78(13):3484–3496.
  • Wen X, Liu X, Mao Y-P, et al. Long non-coding RNA DANCR stabilizes HIF-1 alpha and promotes metastasis by interacting with NF90/NF45 complex in nasopharyngeal carcinoma. Theranostics. 2018;8(20):5676–5689.
  • Guan D, Altan-Bonnet N, Parrott AM, et al. Nuclear factor 45 (NF45) is a regulatory subunit of complexes with NF90/110 involved in mitotic control. Mol Cell Biol. 2008;28(14):4629–4641.
  • Fung LF, Lo AKF, Yuen PW, et al. Differential gene expression in nasopharyngeal carcinoma cells. Life Sci. 2000;67(8):923–936.
  • Jiang W, Huang H, Ding L, et al. Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability. Oncogene. 2015;34(34):4460–4470.
  • Vumbaca F, Phoenix KN, Rodriguez-Pinto D, et al. Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol Cell Biol. 2008;28(2):772–783.
  • Guo NL, Wan Y-W, Tosun K, et al. Confirmation of gene expression - based prediction of survival in non-small cell lung cancer. Clin Cancer Res. 2008;14(24):8213–8220.
  • Guo Y, Fu P, Zhu H, et al. Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer. Oncol Rep. 2012;27(1):286–292.
  • Chanmee T, Ontong P, Izumikawa T, et al. Hyaluronan production regulates metabolic and cancer stem-like properties of breast cancer cells via hexosamine biosynthetic pathway-coupled HIF-1 signaling. J Biol Chem. 2016;291(46):24105–24120.
  • Zhang W, Zhou X, Yao Q, et al. HIF-1-mediated production of exosomes during hypoxia is protective in renal tubular cells. Am J Physiol Renal Physiol. 2017;313(4):F906–F913.
  • Wang Q-L, Huang W-X, and Zhang P-J, et al. Colorimetric determination of the early biomarker hypoxia-inducible factor-1 alpha (HIF-1 alpha) in circulating exosomes by using a gold seed-coated with aptamer-functionalized Au@Au core-shell peroxidase mimic. Mikrochim Acta. 2020;187(1):61-+.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.